Skip Navigation

Phase IB Part of a Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Monotherapy and In Combination with Immune-Oncology Treatment in Advanced Solid Tumors

Brief Summary

Type:
Other

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT02521844

Study #:
STUDY00147207

Start Date:
Jun 09, 2022

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT02521844

View Complete Trial Details & Eligibility at ClinicalTrials.gov